Search - tctmd.com

Displaying 661 - 680 of 769

Sort: Relevancy | Date

News Daily News

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Caitlin E. Cox

October 06, 2015

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Conference News ESC 2015

NSAIDs Plus Anticoagulants a Bad Combination

Caitlin E. Cox

September 01, 2015

News Conference News ESC 2015

FREEDOM Substudy: CABG, PCI Outcomes Affected by Baseline BP

Yael L. Maxwell

August 30, 2015

News Daily News

Chronic Pacing Linked to Lower Survival After Balloon-Expandable TAVR

August 20, 2015

News Daily News

International Study Links Treatment Variations to Mortality in Acute MI

Yael L. Maxwell

August 14, 2015

News Daily News

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

August 06, 2015

News Daily News

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

July 30, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Yael L. Maxwell

July 10, 2015

News Daily News

Extent of Coronary Calcium Predicts Long-term Mortality Risk in Symptom-Free Patients

Todd Neale

July 09, 2015

News Daily News

Possible Cardiovascular Risk of PPIs Lingers in 2 New Studies

June 18, 2015

News Daily News

Meta-analysis Supports Benefit of Complete Revascularization in STEMI

Todd Neale

June 11, 2015

News Daily News

Ticagrelor Pretreatment May Help Protect Against Periprocedural Myonecrosis in NSTE-ACS

June 04, 2015

News Daily News

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

Caitlin E. Cox

May 29, 2015

News Conference News EuroPCR 2015

PRAGUE-13 Finds No Advantage to Complete Revascularization After Primary PCI

Caitlin E. Cox

May 19, 2015

News Daily News

Despite No Measurable Gain in QoL, Women Still Prefer Radial for Cardiac Cath

Caitlin E. Cox

May 15, 2015

News Daily News

Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI

Todd Neale

May 11, 2015

Advertisement

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

NSAIDs Plus Anticoagulants a Bad Combination

FREEDOM Substudy: CABG, PCI Outcomes Affected by Baseline BP

Chronic Pacing Linked to Lower Survival After Balloon-Expandable TAVR

International Study Links Treatment Variations to Mortality in Acute MI

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Extent of Coronary Calcium Predicts Long-term Mortality Risk in Symptom-Free Patients

Possible Cardiovascular Risk of PPIs Lingers in 2 New Studies

Meta-analysis Supports Benefit of Complete Revascularization in STEMI

Ticagrelor Pretreatment May Help Protect Against Periprocedural Myonecrosis in NSTE-ACS

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

PRAGUE-13 Finds No Advantage to Complete Revascularization After Primary PCI

Despite No Measurable Gain in QoL, Women Still Prefer Radial for Cardiac Cath

Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content